Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer.

Miao MoShiyu TongTao LiXiongbing ZuXiheng Hu

Published in: OncoTargets and therapy (2020)

Serum CXCL13 could serve as a novel diagnostic and prognostic biomarker for PC. CXCL13 signaling might activate oncogenic signaling pathways to promote malignant progression of PC.

Keyphrases

signaling pathway
papillary thyroid
poor prognosis
transcription factor
squamous cell
squamous cell carcinoma
prostate cancer
oxidative stress
young adults
lymph node metastasis